Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Understanding personalised medicine - the e-learning course

Prof Gordon McVie
Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )
4 May 2016

Physical activity may improve prostate cancer prognosis

Dr Ying Wang - American Cancer Society, Atlanta, USA
Physical activity may improve prostate cancer prognosis ( Dr Ying Wang - American Cancer Society, Atlanta, USA )
4 May 2016

Inflammatory microenvironment regulates colorectal cancer progression

Dr Sergei Grivennikov - Fox Chase Cancer Center, Philadelphia, USA
Inflammatory microenvironment regulates colorectal cancer progression ( Dr Sergei Grivennikov - Fox Chase Cancer Center,  Philadelphia, USA )
4 May 2016

Mechanisms of immune escape in non-Hodgkin lymphoma

Dr Riccardo Dalla-Favera - Columbia University Medical Center, New York, USA
Mechanisms of immune escape in non-Hodgkin lymphoma ( Dr Riccardo Dalla-Favera - Columbia University Medical Center, New York, USA )
4 May 2016

'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer

Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA
'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer ( Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA )
4 May 2016

Innovations in assessing patient outcomes

Dr Heather Jim - Moffitt Cancer Center, Tampa, USA
Innovations in assessing patient outcomes ( Dr Heather Jim - Moffitt Cancer Center, Tampa, USA )
3 May 2016

Repopulation of cancer stem cells in therapeutic resistance

Prof Keith Chan - Baylor College of Medicine, Houston, USA
Repopulation of cancer stem cells in therapeutic resistance ( Prof Keith Chan - Baylor College of Medicine, Houston, USA )
3 May 2016

Technologies for personalised cancer immunotherapies

Prof James Heath - California Institute of Technology, Pasadena, USA
Technologies for personalised cancer immunotherapies ( Prof James Heath - California Institute of Technology, Pasadena, USA )
3 May 2016

Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors

Dr Shivaani Kummar - Stanford University, Stanford, USA
Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors ( Dr Shivaani Kummar - Stanford University, Stanford, USA )
3 May 2016

Comment on RESONATE2 and CLL115 trials

Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK
Comment on RESONATE2 and CLL115 trials ( Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK )
29 Apr 2016

Clinical cases employing novel agents in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA
Clinical cases employing novel agents in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA )
29 Apr 2016

Current trials in chronic lymphocytic leukaemia

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Current trials in chronic lymphocytic leukaemia ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
29 Apr 2016